跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
祁 力行
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0002-4476-2600
電子郵件
texchi2
gmail
com
h-index
309
引文
9
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2002
2022
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(14)
資料集
(3)
類似的個人檔案
(6)
指紋
查看啟用 Li-Hsing Chi 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Biological Marker
47%
Ameloblastic Carcinoma
40%
Proteomics
40%
Neoplasm
34%
Malignant Neoplasm
27%
Maxilla
24%
Infection
22%
Metastatic Carcinoma
22%
down Regulation
21%
Squamous Cell Carcinoma
20%
Transcriptomics
20%
Neck Mass
20%
Activin A
20%
Le Fort I Osteotomy
20%
Cervical Lymph Node
20%
Lymph Node Metastasis
20%
Gene Expression Profiling
20%
Plasminogen Activator Inhibitor-2
20%
Amaurosis
20%
Proteinase
20%
Glucose Transporter 4
20%
Hypoplasia
20%
Internal Carotid Artery
20%
Non Small Cell Lung Cancer
20%
Timbetasin
20%
Hypoxia
20%
Basal Ganglia
20%
Seroprevalence
20%
Toxoplasmosis
20%
Survival Analysis
17%
Distant Metastasis
16%
Ameloblastoma
16%
Gelatinase B
15%
Gene Expression
14%
Physical Examination
13%
Overall Survival
13%
Surgical Margin
12%
Radiation Therapy
10%
In Vitro
10%
Squamous Cell Carcinoma Cell
10%
Differential Diagnosis
10%
Cancer of Unknown Primary Origin
10%
Cancer
10%
Laboratory Test
10%
Benign Tumor
10%
Soft Palate
10%
Lymphadenopathy
10%
Biopsy
10%
Surgeon
10%
Immunology and Microbiology
Neck
80%
Squamous Cell
80%
down Regulation
21%
Activin A
20%
Timbetasin
20%
Glucose Transporter
20%
Transcriptomics
20%
Lymph Node
20%
Toxoplasmosis
20%
Seroprevalence
20%
Squamous Cell Carcinoma Cell
11%
Overall Survival
9%
Surgical Margin
8%
Head and Neck Squamous Cell Carcinoma Cell Line
7%
Recurrence Free Survival
7%
Gene Expression
5%
Cervical Lymph Node
5%
Tandem Mass Spectrometry
5%
Biochemistry, Genetics and Molecular Biology
down Regulation
21%
Proteomics
20%
Gene Expression Profiling
20%
Gene Expression
20%
Thymosin Beta-4
20%
RUNX2
20%
GLUT4
20%
Activin
20%
Glucose Transporter
20%
Plasminogen Activator Inhibitor-2
20%
Toxoplasma gondii
20%
Seroprevalence
20%
Protease
20%
MMP9
15%
Gelatinase B
15%
Biomarker Discovery
13%
Overall Survival
10%
INHBA
8%
Cancer Staging
6%